Humacyte grows stable, lifesaving vascular access or replacement segments of patient blood vessels. Growing smooth vascular muscle cells requires accurate real time data to ensure quality, compliance, and speed to market for a broad range of disease conditions. Explore the science of how the PI System helps empower Humacyte’s transformation from trials to safe commercialization of Humacyl  a biologic vessel alternative to synthetic vessels.